Clinical trials sponsored by Institute of Cancer Research, United Kingdom

Phase breakdown

Conditions studied

Recruiting trials led by Institute of Cancer Research, United Kingdom

• A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
  NCT05613023 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 42 locations
• Combination Study of Antibiotics With Enzalutamide (PROMIZE)
  NCT06126731 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations
• Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer
  NCT04595019 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
  NCT07002320 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 4 locations
• Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC
  NCT07718243 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
  NCT03946202 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
  NCT03740893 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Precision Medicine in the Prostate Cancer Care Pathway
  NCT04763317 · Phase: Not specified · Ages: 30 Years to 70 Years · Sex: Male · 1 location
• The Active Surveillance Study
  NCT05810467 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 4 locations
• The COherence of Scatter Identification and Exclusion Algorithm Study
  NCT06975579 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
  NCT02543905 · Phase: Not specified · Ages: 40 Years to 69 Years · Sex: Male · 1 location

Common questions

How many trials is Institute of Cancer Research, United Kingdom recruiting for?

Institute of Cancer Research, United Kingdom is the lead sponsor of 11 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.